The mitochondrial toxin 3-nitropropionic acid (3-NP) has been largely used to study neurodegenerative disorders in which bioenergetic defects are implicated. In the present study, we analyzed the molecular pathways involved in FK506 neuroprotection against cell death induced by 3-NP, using cultured cortical neurons. 3-NP induced cytochrome c release and increased caspases -2, -3, -8, and -9-like activities, although, calpain activity was not significantly affected. FK506 decreased cytochrome c release and caspase-3-like activity induced by 3-NP, without changing the activities of other caspases. FK-506 also decreased the number of apoptotic neurons, determined by Hoechst. Under these conditions, FK506 alone significantly reduced calcineurin activity by about 50%. Our results also showed a decrease in mitochondrial Bax and an increase in mitochondrial Bcl-2 levels upon exposure to FK506 and 3-NP. However, no significant changes occurred in total Bcl-2 and Bax levels. Altogether, the results suggest that FK506 neuroprotection against 3-NP-induced apoptosis is associated with the redistribution of Bcl-2 and Bax in the mitochondrial membrane. D
Introduction
Neurodegenerative diseases are thought to be associated with the impairment of neuronal energy metabolism. Several studies have reported the occurrence of mitochondrial dysfunction in brains from Huntington disease (HD) patients, namely, through the inhibition of respiratory chain complexes II and III (Browne et al., 1997; Gu et al., 1996) . Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase, was shown to elicit behavioral abnormalities and cortical and striatal neuronal degeneration in rats and nonhuman primates, similar to that seen in humans with HD (Beal et al., 1993; Brouillet et al., 1998) .
3-NP produces neuronal death secondary to perturbed intracellular calcium homeostasis. In primary rat neuronal cultures, 3-NP induces a gradual increase in mitochondrial calcium and reactive oxygen species which are prevented in the presence of caspase inhibitors (Lee et al., 2002a) . At higher concentrations, 3-NP administration results in a massive elevation of mitochondrial and cytosolic calcium, a decrease in ATP levels, a rapid mitochondrial membrane depolarization, and the activation of calpains (Lee et al., 2002b; Nasr et al., 2003; Pang and Geddes, 1997) . Under these conditions, caspase activity is not affected, which is in agreement with cells undergoing death by necrosis (Nasr et al., 2003) . On the other hand, apoptotic cell death induced by 3-NP has been largely documented through the analysis of DNA fragmentation by TUNEL staining, the release of cytochrome c, the activation of caspase-3, and alterations in the levels of the apoptosis-related protein markers Bax and Bcl-2 (Kim and Chan, 2001; Rodrigues et al., 2000; Vis et al., 2002) .
FK506 has been described to act as a selective inhibitor of calcineurin (or protein phosphatase 2B) (Griffith et al., 1995; Liu et al., 1991) , a ubiquitously expressed Ca 2+ /CaM-dependent protein phosphatase that is a critical component of several Ca 2+ -dependent signaling pathways. Calcineurin regulates a number of transcription factors and ion channels and is involved in long-term depression of postsynaptic potential and synaptic vesicle recycling (Crabtree, 2001; Kramer et al., 2003) . Calcineurin has been also implicated in neuronal cell death induced by insults that elevate cytosolic calcium (Ankarcrona et al., 1996; Agostinho and Oliveira, 2003; Wang et al., 1999; Wood and Bristow, 1998 
